H2020FP7
Merck Sharp & Dohme Corp
- Country
- USUnited States
- Defence projects
- 0
- Projects, all programmes
- 21
- As coordinator
- 0
- EU contribution (CORDIS)
- EUR 0
- Active
- 2009 to 2020
Projects
21 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| PharmaLedgerPharmaLedger | H2020 | 2020 | Participant | EUR 0 |
| PREMIERPrioritisation and Risk Evaluation of Medicines in the EnviRonment | H2020 | 2020 | Participant | EUR 0 |
| NeuroDeRiskNeurotoxicity De-Risking in Preclinical Drug Discovery | H2020 | 2019 | Participant | EUR 0 |
| TransBioLineTranslational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease | H2020 | 2019 | Participant | EUR 0 |
| VITALVaccines and Infectious Diseases in the Ageing PopuLation | H2020 | 2019 | Participant | EUR 0 |
| imSAVARImmune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies | H2020 | 2019 | Participant | EUR 0 |
| PARADIGMPatients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes. | H2020 | 2018 | Participant | EUR 0 |
| DO-ITBig Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055 | H2020 | 2017 | Participant | EUR 0 |
| IB4SD-TRISTANImaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106 | H2020 | 2017 | Participant | EUR 0 |
| PREFERPatient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 | H2020 | 2016 | Participant | EUR 0 |
| VSV-EBOPLUSSYSTEMS ANALYSIS OF ADULT AND PEDIATRIC RESPONSES TO THE VSV-ZEBOV EBOLA VACCINE - Sofia ref.: 116068 | H2020 | 2016 | Participant | EUR 0 |
| EPADEuropean Prevention of Alzheimer’s Dementia Consortium | FP7 | 2015 | Participant | Not stated |
| ADAPT-SMARTAccelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes - Sofia ref.: 115890 | H2020 | 2015 | Participant | EUR 0 |
| IPIEIntelligent Assessment of Pharmaceutical in the Environment | FP7 | 2015 | Participant | Not stated |
| DRIVE-ABDRIVING RE-INVESTMENT IN R&D AND RESPONSIBLE ANTIBIOTIC USE | FP7 | 2014 | Participant | Not stated |
| GETREALIncorporating real-life clinical data into drug development | FP7 | 2013 | Participant | Not stated |
| ADVANCEAccelerated Development of Vaccine benefit-risk Collaboration in Europe | FP7 | 2013 | Participant | Not stated |
| EUPATIEuropean Patients' Academy on Therapeutic Innovation | FP7 | 2012 | Participant | Not stated |
| ORBITOOral biopharmaceutics tools | FP7 | 2012 | Participant | Not stated |
| RAPP-IDDevelopment of RApid Point-of-Care test Platforms for Infectious Diseases | FP7 | 2011 | Participant | Not stated |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.